Company

NEXT Life Sciences, Inc.

NEXT Life Sciences develops a reversible, non-hormonal male contraceptive.

About

NEXT Life Sciences is developing Plan A, a male birth control procedure that uses a hydrogel to stop the passage of sperm. The company is based in San Luis Obispo, US. It received USD 200,000 in grant funding from Male Contraceptive Initiative in January 2025.

2Funding rounds

7Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in